Searle Pakistan launches first generic Remedesivir injection for Covid-19 in Pakistan

Searle Pakistan launches the first generic Remedesivir injection for COVID-19 patients’ treatment in Pakistan.

Searle Pakistan launches the first generic Remedesivir injection for the cure of  COVID-19 patients in Pakistan. The Searle Company Limited delivered its first consignment of Remdesivir injection for hospitalized patients of COVID-19.

interesting reading:  Matthew Willsher Joins As New CEO Ufone and President PTCL

Searle expressed its deep gratitude to the management of Beximco and to the Pakistani authorities for their generous and timely support. Searle has always proudly upheld its socially responsible values inspiring it to step up and vow to offer its services in fighting this crisis by doing its part in awareness, prevention, detection and management of the COVID-19 pandemic.

The Searle Company Limited under it’s exclusive license and marketing agreement of Covid-19 drug Remdesivir, successfully launched the Remedesivir injection. Searle Pakistan recently signed an agreement with Beximco Pharmaceuticals, Bangladesh for marketing of Covid-19 drug Remedesivir.   

This friendly collaboration will provide a rapid supply of the finished product at reasonable cost and will also help the healthcare workers of Pakistan to treat the hospitalized COVID-19 patients without a second delayed.   

Initially, Searle is aiming to import Remdesivir in a ready-to-use form so as to fulfill the urgent requirements of the country.

interesting reading:  Global Study: 82% of People Believe Robots Can Support Their Mental Health Better Than Humans

Moreover, Searle is also planning to generously donate a substantial quantity of Remdesivir to the government of Pakistan which is actively counteracting the pandemic.  

World’s pharmaceutical companies contend to invent cure along with a substantial vaccine for COVID-19. Gilead has stunned the world by making constructive efforts against the virus.

Basically, Remdesivir has been tested and turns out it has the capacity to shrink the amount of time required for COVID-19 patients’ recovery.   

interesting reading:  SHC Seeks Scientific Action For Virginity Tests In Rape Cases

Remdesivir, in actual, was prepared to help treat the patients of hepatitis C. Surprisingly, the substance has showed its multitasking capability as Remdesivir can help treating a number of other virus.

It counteracted three major diseases few years back that wiped a colossal amount of population from the globe, Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and the Ebola virus.

Although it is not approved as a fully efficient treatment for the diseases,  it, somehow, was handy in the past crises.


3 thoughts on “Searle Pakistan launches first generic Remedesivir injection for Covid-19 in Pakistan

  • June 4, 2020 at 6:11 pm

    This is absolutely nonsense
    As you don’t find it any where like WHO or even at Seattle official website
    You take money to give wrong impression

    • Paras Ali
      June 5, 2020 at 12:37 am

      Thanks for your intimation, we made correction as per company’s statement.


Leave a Reply

Your email address will not be published. Required fields are marked *

Captcha loading...